HEADER HORMONE/GROWTH FACTOR 31-OCT-02 1N4H TITLE CHARACTERIZATION OF LIGANDS FOR THE ORPHAN NUCLEAR RECEPTOR RORBETA COMPND MOL_ID: 1; COMPND 2 MOLECULE: NUCLEAR RECEPTOR ROR-BETA; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: LIGAND-BINDING DOMAIN; COMPND 5 SYNONYM: NUCLEAR RECEPTOR RZR-BETA; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: STEROID RECEPTOR COACTIVATOR-1; COMPND 9 CHAIN: B; COMPND 10 FRAGMENT: NR-2 BOX; COMPND 11 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: RATTUS NORVEGICUS; SOURCE 3 ORGANISM_COMMON: NORWAY RAT; SOURCE 4 ORGANISM_TAXID: 10116; SOURCE 5 GENE: RZR-BETA; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21 DE3; SOURCE 9 EXPRESSION_SYSTEM_TISSUE: BRAIN; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: PET15B; SOURCE 12 MOL_ID: 2; SOURCE 13 SYNTHETIC: YES; SOURCE 14 OTHER_DETAILS: THE PEPTIDE WAS CHEMICALLY SYNTHESIZED. THE SEQUENCE SOURCE 15 OF THE PEPTIDE IS NATURALLY FOUND IN HOMO SAPIENS (HUMAN). KEYWDS ALPHA-HELICAL SANDWICH, PROTEIN-PEPTIDE-LIGAND COMPLEX, HORMONE- KEYWDS 2 GROWTH FACTOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR C.STEHLIN-GAON,D.WILLMANN,S.SANGLIER,A.VAN DORSSELAER,J.-P.RENAUD, AUTHOR 2 D.MORAS,R.SCHUELE REVDAT 3 14-FEB-24 1N4H 1 REMARK REVDAT 2 24-FEB-09 1N4H 1 VERSN REVDAT 1 23-SEP-03 1N4H 0 JRNL AUTH C.STEHLIN-GAON,D.WILLMANN,D.ZEYER,S.SANGLIER, JRNL AUTH 2 A.VAN DORSSELAER,J.-P.RENAUD,D.MORAS,R.SCHUELE JRNL TITL ALL-TRANS RETINOIC ACID IS A LIGAND FOR THE ORPHAN NUCLEAR JRNL TITL 2 RECEPTOR RORBETA JRNL REF NAT.STRUCT.BIOL. V. 10 820 2003 JRNL REFN ISSN 1072-8368 JRNL PMID 12958591 JRNL DOI 10.1038/NSB979 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH C.STEHLIN,J.M.WURTZ,A.STEINMETZ,E.GREINER,R.SCHULE,D.MORAS, REMARK 1 AUTH 2 J.P.RENAUD REMARK 1 TITL X-RAY STRUCTURE OF THE ORPHAN NUCLEAR RECEPTOR RORBETA REMARK 1 TITL 2 LIGAND-BINDING DOMAIN IN THE ACTIVE CONFORMATION REMARK 1 REF EMBO J. V. 20 5822 2001 REMARK 1 REFN ISSN 0261-4189 REMARK 1 DOI 10.1093/EMBOJ/20.21.5822 REMARK 1 REFERENCE 2 REMARK 1 AUTH J.P.RENAUD,N.ROCHEL,M.RUFF,V.VIVAT,P.CHAMBON,H.GRONEMEYER, REMARK 1 AUTH 2 D.MORAS REMARK 1 TITL CRYSTAL STRUCTURE OF THE RAR-GAMMA LIGAND-BINDING DOMAIN REMARK 1 TITL 2 BOUND TO ALL-TRANS RETINOIC ACID REMARK 1 REF NATURE V. 378 681 1995 REMARK 1 REFN ISSN 0028-0836 REMARK 1 DOI 10.1038/378681A0 REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 3.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 19024 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.217 REMARK 3 FREE R VALUE : 0.255 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 16820 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2066 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 22 REMARK 3 SOLVENT ATOMS : 113 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -3.66200 REMARK 3 B22 (A**2) : 0.00000 REMARK 3 B33 (A**2) : 4.87000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -1.20800 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.27 REMARK 3 ESD FROM SIGMAA (A) : 0.08 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : 18.10 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.630 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : REAM.PARAM REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1N4H COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 04-NOV-02. REMARK 100 THE DEPOSITION ID IS D_1000017507. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 11-NOV-01 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : BM14 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.976205 REMARK 200 MONOCHROMATOR : SI 111 CHANNEL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 19390 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : NULL REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.17 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: PDB ENTRY 1K4W REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.01 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.56 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 6000, PH 8.0, VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 295K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 26.09950 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 53.01950 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 29.06250 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 53.01950 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 26.09950 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 29.06250 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 THIS ENTRY CONTAINS THE CRYSTALLOGRAPHIC ASYMMETRIC UNIT REMARK 300 WHICH CONSISTS OF 2 CHAIN(S). THE BIOLOGICAL UNIT IS REMARK 300 UNKNOWN. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1940 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 12310 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -8.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -6 REMARK 465 GLN A -5 REMARK 465 LEU A -4 REMARK 465 ALA A -3 REMARK 465 PRO A -2 REMARK 465 GLY A -1 REMARK 465 ILE A 0 REMARK 465 PRO A 245 REMARK 465 ASP A 246 REMARK 465 CYS A 247 REMARK 465 ALA A 248 REMARK 465 ALA A 249 REMARK 465 VAL A 250 REMARK 465 CYS A 251 REMARK 465 LYS A 252 REMARK 465 ARG B 690 REMARK 465 GLY B 701 REMARK 465 SER B 702 REMARK 465 PRO B 703 REMARK 465 SER B 704 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TRP A 167 -3.29 80.06 REMARK 500 ASN A 192 -125.80 -102.79 REMARK 500 HIS A 193 87.72 -15.14 REMARK 500 ASP A 195 110.41 65.34 REMARK 500 ASP A 196 -117.97 -113.73 REMARK 500 GLU A 197 -5.05 99.87 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE REA A 500 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1K4W RELATED DB: PDB REMARK 900 XRAY STRUCTURE OF THE ORPHAN NUCLEAR RECEPTOR RORBETA LIGAND- REMARK 900 BINDING DOMAIN IN THE ACTIVE CONFORMATION REMARK 900 RELATED ID: 2LBD RELATED DB: PDB REMARK 900 LIGAND-BINDING DOMAIN OF THE HUMAN HUMAN NUCLEAR RECEPTOR RXR-ALPHA DBREF 1N4H A -6 252 UNP P45446 RORB_RAT 201 459 DBREF 1N4H B 690 704 GB 1906028 AAB50242 686 700 SEQRES 1 A 259 GLY GLN LEU ALA PRO GLY ILE THR MET SER GLU ILE ASP SEQRES 2 A 259 ARG ILE ALA GLN ASN ILE ILE LYS SER HIS LEU GLU THR SEQRES 3 A 259 CYS GLN TYR THR MET GLU GLU LEU HIS GLN LEU ALA TRP SEQRES 4 A 259 GLN THR HIS THR TYR GLU GLU ILE LYS ALA TYR GLN SER SEQRES 5 A 259 LYS SER ARG GLU ALA LEU TRP GLN GLN CYS ALA ILE GLN SEQRES 6 A 259 ILE THR HIS ALA ILE GLN TYR VAL VAL GLU PHE ALA LYS SEQRES 7 A 259 ARG ILE THR GLY PHE MET GLU LEU CYS GLN ASN ASP GLN SEQRES 8 A 259 ILE LEU LEU LEU LYS SER GLY CYS LEU GLU VAL VAL LEU SEQRES 9 A 259 VAL ARG MET CYS ARG ALA PHE ASN PRO LEU ASN ASN THR SEQRES 10 A 259 VAL LEU PHE GLU GLY LYS TYR GLY GLY MET GLN MET PHE SEQRES 11 A 259 LYS ALA LEU GLY SER ASP ASP LEU VAL ASN GLU ALA PHE SEQRES 12 A 259 ASP PHE ALA LYS ASN LEU CYS SER LEU GLN LEU THR GLU SEQRES 13 A 259 GLU GLU ILE ALA LEU PHE SER SER ALA VAL LEU ILE SER SEQRES 14 A 259 PRO ASP ARG ALA TRP LEU LEU GLU PRO ARG LYS VAL GLN SEQRES 15 A 259 LYS LEU GLN GLU LYS ILE TYR PHE ALA LEU GLN HIS VAL SEQRES 16 A 259 ILE GLN LYS ASN HIS LEU ASP ASP GLU THR LEU ALA LYS SEQRES 17 A 259 LEU ILE ALA LYS ILE PRO THR ILE THR ALA VAL CYS ASN SEQRES 18 A 259 LEU HIS GLY GLU LYS LEU GLN VAL PHE LYS GLN SER HIS SEQRES 19 A 259 PRO ASP ILE VAL ASN THR LEU PHE PRO PRO LEU TYR LYS SEQRES 20 A 259 GLU LEU PHE ASN PRO ASP CYS ALA ALA VAL CYS LYS SEQRES 1 B 15 ARG HIS LYS ILE LEU HIS ARG LEU LEU GLN GLU GLY SER SEQRES 2 B 15 PRO SER HET REA A 500 22 HETNAM REA RETINOIC ACID FORMUL 3 REA C20 H28 O2 FORMUL 4 HOH *113(H2 O) HELIX 1 1 THR A 1 CYS A 20 1 20 HELIX 2 2 THR A 23 ALA A 31 1 9 HELIX 3 3 THR A 36 LYS A 46 1 11 HELIX 4 4 SER A 47 ARG A 72 1 26 HELIX 5 5 ILE A 73 GLU A 78 1 6 HELIX 6 6 CYS A 80 CYS A 101 1 22 HELIX 7 7 GLY A 119 GLY A 127 5 9 HELIX 8 8 SER A 128 SER A 144 1 17 HELIX 9 9 THR A 148 ILE A 161 1 14 HELIX 10 10 GLU A 170 ASN A 192 1 23 HELIX 11 11 GLU A 197 ALA A 204 1 8 HELIX 12 12 LYS A 205 HIS A 227 1 23 HELIX 13 13 HIS A 227 LEU A 234 1 8 HELIX 14 14 PRO A 236 ASN A 244 1 9 HELIX 15 15 HIS B 691 GLU B 700 1 10 SHEET 1 A 3 PHE A 104 ASN A 105 0 SHEET 2 A 3 THR A 110 PHE A 113 -1 O THR A 110 N ASN A 105 SHEET 3 A 3 LYS A 116 GLY A 118 -1 O LYS A 116 N PHE A 113 SITE 1 AC1 8 GLN A 21 TYR A 22 CYS A 55 ARG A 99 SITE 2 AC1 8 VAL A 111 LEU A 112 HOH A 801 HOH A 823 CRYST1 52.199 58.125 106.039 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019157 0.000000 0.000000 0.00000 SCALE2 0.000000 0.017204 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009430 0.00000